Hong Lu

机构：First Affiliated Hospital of Zhengzhou University

发表论文 15 篇 · 总被引 607 次 · h-index 9

代表论文

• LncRNA PVT1 regulates ferroptosis through miR-214-mediated TFR1 and p53 (2020 · Life Sciences · 被引 296)
• Dopaminergic neuron injury in Parkinson’s disease is mitigated by interfering lncRNA SNHG14 expression to regulate the miR-133b/ α-synuclein pathway (2019 · Aging · 被引 66)
• RETRACTED ARTICLE: Long noncoding RNA HAGLROS regulates apoptosis and autophagy in Parkinson’s disease via regulating miR-100/ATG10 axis and PI3K/Akt/mTOR pathway activation (2019 · Artificial Cells Nanomedicine and Biotechnology · 被引 66)
• TAZ promotes temozolomide resistance by upregulating MCL-1 in human glioma cells (2015 · Biochemical and Biophysical Research Communications · 被引 57)
• Interleukin 8 (CXCL8)-CXC chemokine receptor 2 (CXCR2) axis contributes to MiR-4437-associated recruitment of granulocytes and natural killer cells in ischemic stroke (2018 · Molecular Immunology · 被引 34)
• Collagen peptide modified carboxymethyl cellulose as both antioxidant drug and carrier for drug delivery against retinal ischaemia/reperfusion injury (2018 · Journal of Cellular and Molecular Medicine · 被引 26)